09 / 08 / 2022
Save the date for our new in vivo shuttle campaign!
We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform.
Sign up! It’s for early November
09 / 01 / 2022
Annals of Oncology, 2022, July 15
F Peyraud, J-P Guegan, D Bodet, I Nafia, L Fontan, C Auzanneau, S Cousin, G Roubaud, M Cabart, F Chomy, F Le Loarer, N Chaput, F-X Danlos, D Planchard, C Even, M Khettab, L Tselikas, B Besse, F Barlesi, J-C Soria, A Marabelle, A Bessede, A Italiano
08 / 01 / 2022
A novel gut-restricted small molecule TLR2 agonist enhances immune checkpoint inhibitor efficacy in a preclinical mouse fibrosarcoma tumor model
European journal of cancer, 2022, October 1
J. Simon, C.J. Oalmann, P. Stern, R.K. Senter, M. Chien, R. Graf, A. Bessede, A.S. Campbell
07 / 12 / 2022
Check out - it's our favorite image of the month
What a pretty multiplexed image showing the tumor microenvironment (TME) on a human NSCLC section, highlighting PDL1 positive tumor cells surrounded by macrophages and T cells.
07 / 07 / 2022
Discover our main news for the first half of 2022!
Hear about the great opportunity that is our partnership with Domain Therapeutics, new cutting-edge platforms for biomarker translational research as well as our newest featured publication!
06 / 29 / 2022
Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small cell lung cancer
Annals of Oncology, 2022, June 2906 / 23 / 2022
Ascites is a pathological peritoneal fluid accumulation most frequently associated with ovarian cancer, among few others, thereby creating a quite unique tumor microenvironment in which cancer cells spread.
06 / 16 / 2022
In this collaborative work, researchers from Institut Bergonié, Institut Gustave Roussy, and Explicyte, demonstrated that presence of APAP in plasma from cancer patients before they undergo immunotherapy was independently associated with a worse clinical outcome.
06 / 16 / 2022
Check out - it's our favorite image of the month
Summer beginning, look at a real fireworks 🎆! Human cerebral cortex nerve cells lit up on section!
06 / 02 / 2022
Through this study, authors depicted the association between the enrichment of Tumor Associated Macrophages (TAMs) in the Tumor Micro Environment (TME) of Non-Small Cell Lung Cancer (NSCLC) and the resistance to immunotherapy, regardless of the programmed death ligand 1 status.